linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Bafna Pharmaceuticals Ltd.
 
Source DateBoard Meeting DateDetails
21 May 202629 May 2026 Audited Results
05 Feb 202611 Feb 2026 Quarterly Results
06 Nov 202511 Nov 2025 Quarterly Results
07 Aug 202512 Aug 2025 Quarterly Results
19 May 202526 May 2025 Audited Results
28 Jan 202506 Feb 2025 Quarterly Results
04 Nov 202411 Nov 2024 Quarterly Results
06 Aug 202413 Aug 2024 Quarterly Results
23 May 202429 May 2024 Audited Results
02 Feb 202412 Feb 2024 Quarterly Results
30 Oct 202309 Nov 2023 Quarterly Results
03 Aug 202311 Aug 2023 Quarterly Results
23 Jun 202326 Jun 2023 Inter alia, to consider and approve the appointment of : 1. Mr. Vinayak Dinesh Dendukuri (DIN: 07601309) as Additional Director designated as Whole-time Director ? Operation. 2. Mr. Upendar Mekala Reddy (DIN: 08898174) as Additional Director designated as Non-Executive Non-independent Director; 3. Mr. Krishna Yeachuri (DIN: 00066898) as Additional Director designated as Non-Executive Independent Director, and any other business with the permission of the Chair.
23 May 202327 May 2023 Audited Results (Revised)
17 May 202324 May 2023 Audited Results
05 Apr 202307 Apr 2023 Inter alia, to consider and approve the appointment of Company Secretary cum Compliance Officer and any other business with the permission of the Chair
01 Feb 202308 Feb 2023 Quarterly Results
02 Nov 202211 Nov 2022 Quarterly Results
04 Aug 202211 Aug 2022 Quarterly Results
20 May 202226 May 2022 Audited Results
Page 1 of 5
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.